2022
DOI: 10.1016/j.sbi.2022.102379
|View full text |Cite
|
Sign up to set email alerts
|

Advances in computational structure-based antibody design

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
40
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
2
2

Relationship

0
9

Authors

Journals

citations
Cited by 61 publications
(41 citation statements)
references
References 60 publications
0
40
0
1
Order By: Relevance
“…The antibodies recognize the antigens using the hypervariable complementarity-determining region (CDR) loops. The main issue in antibody structure prediction is the modeling of the CDRs, especially the CDR-H3 loop 39, 40 , and the conformations of these loops may even change upon binding 41 . Indeed, our failures to predict the antibody-antigen complexes seem to be related to incorrect positioning of CDR loops in the antibody structures (Supplementary Figure S7).…”
Section: Resultsmentioning
confidence: 99%
“…The antibodies recognize the antigens using the hypervariable complementarity-determining region (CDR) loops. The main issue in antibody structure prediction is the modeling of the CDRs, especially the CDR-H3 loop 39, 40 , and the conformations of these loops may even change upon binding 41 . Indeed, our failures to predict the antibody-antigen complexes seem to be related to incorrect positioning of CDR loops in the antibody structures (Supplementary Figure S7).…”
Section: Resultsmentioning
confidence: 99%
“…For a better comprehension of assay specificity, an in-silico model was used to compare the experimental results with computational data. Computational modelling methods for the in-silico construction of the 3D structure of monoclonal antibodies (mAbs) have been already developed and applied in drug discovery [ 60 , 61 ], while their exploitation to support immunosensor development is not yet widespread. Furthermore, many immunosensors employ polyclonal antibodies (pAbs) rather than mAbs, taking advantage of their higher binding avidity and affinity [ 62 , 63 ].…”
Section: Resultsmentioning
confidence: 99%
“…Learnings from antibodies are being transferred to their sisterly format such as nanobodies [ 18 , 135 , 141 ]. Of note, synergies between existing data sources provide novel findings, such as employing structural information to annotate large NGS datasets [ 76 , 95 , 142–144 ]. The increasing momentum of computational methods is therefore encouraging to speed up the development of therapeutics by the biotechnology industry.…”
Section: Discussionmentioning
confidence: 99%
“…Such virtual screening attempts in the field of small molecules are often combined with large-scale docking [ 90 ]. Deep learning models are increasingly used to score the different docking poses for protein–protein functions in general [ 91–93 ], with antibody–antigen docking treated as a separate case [ 85 , 94 ] (reviewed recently [ 95 ]). Docking was employed recently by deep learning for antibodies (DLAB) to address virtual screening by rescoring ZDOCK [ 96 ] poses in an antibody-specific fashion.…”
Section: Embedding the Ab-ag Space: Prediction Of Antibody–antigen Bi...mentioning
confidence: 99%